VXRT News and Press, Vaxart Inc. From 06/15/20

Vaxart (NASDAQ: VXRT ) appoints Andrei Floroiu as Chief Executive Officer (CEO). More news on: Vaxart, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Andrei Floroiu Appointed Chief Executive Officer Wouter Latour, MD, to Continue as Chairman of the Board SOUTH SAN FRANCISCO, Calif., June 15, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NasdaqCM: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotec...

June 3, 2020 Palm Beach, FL – June 3, 2020 – Rapid development of a vaccine to prevent the global health crisis is a global imperative, and defining the stakes and potential hurdles is critical because regulatory and medical decisions are based on benefit/risk calcul...

SOUTH SAN FRANCISCO, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc.  (“Vaxart” or the “Company”) (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, to...

Introduction Think about it: the world is having a health crisis and what do we do? We created the largest global collapse since 1929! And as noted in prior columns , we are now at a point where nobody wanted to go: we must continually ask: do we continue the global “lockdownȁ...

In a note, Evercore ISI's Joshua Schimmer says Moderna's (NASDAQ: MRNA ) COVID-19 vaccine, mRNA-1273, is unlikely to be the best of the bunch but may wind up being "good enough" to get the first regulatory nod, adding that other candidates appear poised to offer higher immunogenicity, fewer ...

Safe-T Group (NASDAQ: SFET ) +44%  as its wholly owned subsidiary, NetNut has expanded into a new market with the signing of agreements with three leading companies operating in the consumer VPN sector. More news on: Safe-T Group Ltd, Surface Oncology, Inc., Cheetah Mobile Inc., St...

Kindred Biosciences (NASDAQ: KIN ) inks an agreement  with Vaxart (NASDAQ: VXRT ) to manufacture its oral COVID-19 vaccine candidate at its Burlingame, CA site. Its contract development and manufacturing efforts are managed by subsidiary Centaur Biopharmaceutical Services. More news ...

KindredBio Selected as Second Contract Manufacturing Organization GMP Production for Phase 1 Study Initiated SOUTH SAN FRANCISCO, Calif., May 20, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (“Vaxart” or the “Company”) (NASDAQ: VXRT), a clinical-stage biotechno...

SAN FRANCISCO , May 20, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company developing novel biologics, today announced it has entered into an agreement with Vaxart, Inc. (Nasdaq: VXRT) for the manufacture of Vaxart's oral vaccine candidate for C...